Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,840.00
-160.00 (-1.60%)
Aug 21, 2026, 3:30 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 181.88 billion as of August 21, 2026. Its market cap has increased by 5.61% in one year.
Market Cap
181.88B
Enterprise Value
115.81B
Revenue
273.47B
Ranking
n/a
PE Ratio
8.40
Stock Price
9,840.00
ChartMarket Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 181.88B, an increase of 255.10%. That is a compound annual growth rate of 4.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 181.88B | 5.24% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 220.89B |
| Boditech Med | 212.61B |
| REYON Pharmaceutical | 185.98B |
| Chong Kun Dang Holdings | 185.66B |
| FutureChem Co.,Ltd | 180.27B |
| JW Lifescience | 174.98B |
| AptaBio Therapeutics | 174.46B |
| BNC KOREA | 169.62B |